FDA approves CAD system for lung cancer screening

Deus Technologies got the nod from the FDA to begin selling its RapidScreen RS-2000 to assist in the detection of early-stage lung cancer. The computer-assisted detection system digitizes and analyzes chest radiographs to identify regions of interest that may have features associated with early-stage lung cancer. The system uses image enhancement and pattern recognition techniques to locate suspicious areas that may warrant a second review by a radiologist. Deus developed the software using thousands of existing chest images as training data sets. The software contains elements of artificial neural networks and fuzzy logic technology.